Sign up for our FREE Weekly Newsletter
Current Issue
Past Issue
News and Information for Medical Professionals
Search Diabetes In Control
 
 
Bookmark and Share | Print | Category | Home Previous | Next
This article originally posted 23 August, 2009 and appeared in  Issue 483
Test Your Knowledge #483

A 74-year-old man who has had Type 2 diabetes for 20 years is evaluated for possible initiation of insulin treatment. He takes metformin 1000 mg twice daily and glyburide 10 mg twice daily. He recently began measuring his preprandial blood glucose level; his home blood glucose profile for the past week is as follows:

 
BLOOD GLUCOSE VALUE, mg/dL
 
Breakfast
Lunch
Dinner
 
Day
Pre
Post
Pre
Post
Pre
Post
Bedtime
Sun
179
212
202
234
Mon
196
234
186
214
Tue
187
199
212
194
Wed
199
187
198
184
Thu
169
156
172
215
Fri
178
177
176
206
Sat
188
190
201
225
Pre = preprandial; post = 2-hour postprandial.

He follows a reasonable meal plan with consistent carbohydrate intake at each meal. His exercise routine is to walk for 20 minutes three times per week. Relevant laboratory data are a hemoglobin A1c value of 9.4% and a serum creatinine concentration of 1.8 mg/dL (159.16 µmol/L). Results of liver function tests are normal.

QUESTION:

To lower glucose levels to an acceptable target in this patient, which of the following is the most appropriate adjustment of his treatment regimen?

A. Continue metformin and glyburide, and start basal insulin at night.

 

B. Continue metformin and glyburide, and start 70/30 premixed insulin before supper.

 
C. Stop metformin, continue glyburide, and add rosiglitazone.
 

D. Stop metformin and glyburide, and start 70/30 premixed insulin twice daily.

 

 

Bookmark and Share | Print | Category | Home

This article originally posted 23 August, 2009 and appeared in  Issue 483

Past five issues: Issue 495 | Issue 494 | Issue 493 | Issue 492 | Issue 491 |

Recent Most Read Articles:

Obesity Reduces Survival By 2 Years
Posted March 31, 2009
Not Enough Sleep Causes More Eating and Diabetes Risk
Posted May 01, 2009
Test Your Knowledge Issue 469
Posted May 19, 2009
Generex Biotechnology Announces Successful Phase III Study Data for Generex Oral-lyn(tm)
Posted March 17, 2009
Test Your Knowledge Issue 457
Posted February 24, 2009
Discovery of a New Receptor Antagonist Predicts Diabetes 2 Onset
Posted April 18, 2009
Letter From The Editor. June 29, 2009 Issue #475
Posted June 29, 2009
Artificial Sweeteners Linked to Two-Fold Increase in Diabetes
Posted June 23, 2009
Lantus Insulin: A Possible Link with Cancer - Requires Further Investigation
Posted June 29, 2009
New Buccal Insulin Approved by the FDA but with Conditions
Posted September 12, 2009

See more most read...


Enhancing physiology; Mechanism targets 2 key defects: insulin release and hepatic glucose production. Click here to learn more.




Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead | Did You Know | Education | Facts | Feature | Items for the Week | New Products | Newsflash | Press Releases | Studies | Test Your Knowledge | Test Your Knowledge Answers | Tools |

Diabetes In Control Advertisers

Print This Week's Newsletter
Download This Week's Newsletter
Newsletter is in Adobe format
If you don't haveAdobe Acrobat Reader , you can download it for Free here .

Free CE Available
CE Programs On Diabetes Available here

Search Articles On Diabetes In Control
Sign up for our FREE Weekly Newsletter
Current Issue
Past Issue
Privacy / Advertising With Us / Contact Us
Add us to your favorite news reader
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.